448. Real World Evaluation of Clinical Outcomes for Short-Duration Remdesivir Therapy in Hospitalized Patients with Mild-Moderate COVID-19

BACKGROUND: The optimal duration of remdesivir for hospitalized patients with COVID-19 remains unclear. National Institute of Health (NIH) Guidelines recommend a standard duration of 5 days or until hospital discharge. This study aims to compare the outcomes of hospitalized patients who received ≤ 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Kelsey N, Gauthier, Timothy P, Baker, Stacey W, Cua, Jefferson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676879/
http://dx.doi.org/10.1093/ofid/ofad500.518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676879/
http://dx.doi.org/10.1093/ofid/ofad500.518

Ejemplares similares